NASDAQ: APLS Investor Alert: Lawsuit Alleges Misleading Statements by Apellis Pharmaceuticals, Inc.
An investor, who purchased shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), filed a lawsuit over alleged violations of Federal Securities Laws by Apellis Pharmaceuticals, Inc..
View full press release